Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
House conservatives to lead prayer for end to...
GOP senators push for Charlie Kirk statue in...
Biden autopen investigation ‘has heated up’ as DOJ...
States sue Trump admin over billions in looming...
NASA’s ‘quiet’ supersonic jet completes first flight in...
Trump claims Asia tour returned ‘trillions’ to US...
‘Unprecedented’ panel of federal judges will tackle antisemitism...
Schumer, Dems call ‘bull—-‘ on Trump administration over...
US rescue teams to descend on hard-hit Caribbean...
Republicans dub Fetterman ‘voice of reason’ after he...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by admin January 19, 2025
January 19, 2025
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

previous post
Obama wishes wife Michelle happy birthday as she stays away from key public events
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

You may also like

SEC dropping crypto lawsuit, Coinbase says

February 22, 2025

Comcast to announce the spinoff of cable networks,...

November 21, 2024

Fanatics will host a skills challenge between fans...

May 22, 2025

Biden administration seeks to avoid default crisis for...

January 17, 2025

All Quiksilver, Billabong and Volcom stores to close...

February 7, 2025

India’s 2nd-wealthiest person charged by U.S. in $250...

November 22, 2024

Procter & Gamble to cut 7,000 jobs as...

June 10, 2025

Retirees ‘stunned’ as market turmoil over tariffs shrinks...

April 6, 2025

Warner Bros. Discovery sues NBA to secure media...

July 29, 2024

Digital health companies got pummeled by Wall Street...

December 26, 2024

Recent Posts

  • House conservatives to lead prayer for end to political violence, government shutdown
  • GOP senators push for Charlie Kirk statue in Trump’s National Garden of American Heroes
  • Biden autopen investigation ‘has heated up’ as DOJ looks at Delaware, DC: source
  • States sue Trump admin over billions in looming cuts to SNAP, food stamps
  • NASA’s ‘quiet’ supersonic jet completes first flight in potential breakthrough for commercial air travel

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (946)
    • Investing (3,304)
    • Politics (4,045)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.